Submission Rules & Guidelines
General


Topics

  • Abstracts must be in the areas of interventional pulmonology, laryngology, pleural diseases, tracheobronchology, thoracic surgery, and/or esophagology.

Evaluation

  • Abstract submissions will be reviewed by the Abstracts Review Committee for acceptance.
  • Abstract acceptance notifications will be sent to authors by email no later than May 15, 2018.

Publication

  • Accepted abstracts will be published in the scientific and online programs of the 20th WCBIP/WCBE World Congress.
  • Accepted abstracts will be published in the World Congress Scientific Program, and on the 20th WCBIP/WCBE World Congress App.

The Heinrich Becker Young Investigator Awards for Research and Clinical Innovation

  • Awards will be presented to 3 registered participants whose abstracts suggest a significant contribution through research or clinically innovative techniques to the fields of bronchology and interventional pulmonology.
  • To be eligible for this award, the first author and/or principal investigator must be a registered attendee of the 20th WCBIP/WCBE World Congress.
  • Eligible participants may apply for the awards by clicking YES on the appropriate checkbox on the submission form.
  • Visit https://www.wabip.com/awards/becker for more information about these awards.

Length, style, and formatting

  • Abstracts should have a clear hypothesis and methodology, list all author names and institutions, and designate a corresponding author.
  • The body of text can be a maximum of 400 words and include 1 figure or table as an image file. Tables and figures do not count towards the total word count.
  • Abstracts should be written in a structured format and include: Title, Authors names, Authors affiliations, Background, Methods, Results, and Conclusion.
  • Case reports are also acceptable and should be identified as such on the submission form. Case reports should be structured as follows: Title, Authors names, Authors affiliations, Background, Case report, and Conclusion.
  • The abstracts title should begin with a capital letter followed by lower case lettering.

Originality and linguistic accuracy

  • Abstracts must contain original data, be free of plagiarism, and be written and submitted in English.
  • The linguistic accuracy of the abstract is the responsibility of the authors.

Disclosure of funding source(s)

  • Abstracts must provide the funding source (industry name, grant name, or other applicable funding) if one exists.
  • Commercial names, trade names and company brands should not be mentioned in the abstract title; however, they may be mentioned in the body of text.
  • Abstracts containing elements that might lead to patient identification shall be disqualified.

Oral Presentations

  • PowerPoint presentations may be used. The presenter must provide the presentation in advance (deadline: March 1, 2018) by attaching to the application in the PPT link section.

Poster Presentations

  • Text, figures, and images may be included.
  • Posters may be laminated.
  • Recommended size of poster is 4’ x 4’

Copyrights

  • Authors are required to write an original abstract that fulfills accepted criteria for copyright purposes.
  • By submitting an abstract, all authors attest that the abstract submitted has not been previously published elsewhere and transfers, assigns, or otherwise conveys all copyright ownership, including any and all rights incidental thereto, exclusively to WABIP/IBES.
  • If an author chooses to submit information from an abstract that has previously been presented and/or published, all data must be updated, current, and rewritten in a manner that does not infringe on international copyright laws. Authors are responsible for obtaining permission to include any copyrighted material in their abstract presentations. All authors will be required to agree to a copyright assignment statement when submitting an abstract.
Submission Form


Submission deadline: March 1, 2018